| Identification | Back Directory | [Name]
Benzenebutanamide, 4-[(1E)-2-(4-butylphenyl)diazenyl]-N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]- | [CAS]
2260670-55-9 | [Synonyms]
Benzenebutanamide, 4-[(1E)-2-(4-butylphenyl)diazenyl]-N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]- | [Molecular Formula]
C38H59N3O3 | [MOL File]
2260670-55-9.mol | [Molecular Weight]
605.89 |
| Chemical Properties | Back Directory | [Boiling point ]
766.5±60.0 °C(Predicted) | [density ]
1.02±0.1 g/cm3(Predicted) | [storage temp. ]
-20°C | [form ]
powder | [pka]
13.53±0.20(Predicted) | [InChIKey]
YLXGVJCCZLVXAT-OYLVPQITSA-N | [SMILES]
OC[C@H](NC(CCCC1=CC=C(/N=N/C2=CC=C(CCCC)C=C2)C=C1)=O)[C@H](O)/C=C/CCCCCCCCCCCCC |
| Hazard Information | Back Directory | [Description]
ACe-1 is a modified ceramide with an azobenzene moiety to allow for optical control of the N-acyl chain. ACe-1 has been shown to enable the reversible switching of lipid domains in raft-mimicking supported bilayers. Research has shown that in the trans- configuration the ACes are in the liquid-ordered phase and in the cis- configuration the ACes are in the liquid disordered phase in lipid rafts. |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|